-
EP1954720
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1954720
| EP1954720 - ANTIBODIES AND IMMUNOTOXINS THAT TARGET HUMAN GLYCOPROTEIN NMB [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 20.03.2009 Database last updated on 02.11.2024 | Most recent event Tooltip | 20.03.2009 | Withdrawal of application | published on 22.04.2009 [2009/17] | Applicant(s) | For all designated states The Government of the United States of America, as represented by the Secretary of Health and Human Services National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325 Rockville, MD 20852-3804 / US | For all designated states Duke University University Office of Science and Technology, Davidson Building, Room 454, DUMC 3664 Durham, NC 27710 / US | [N/P] |
| Former [2008/33] | For all designated states The Government of the United States of America, as Represented by the Secretary of Health and Human Services, National Institu 6011 Executive Boulevard Rockville MD 20852 / US | ||
| For all designated states Duke University University Office of Science and Technology, Davidson Building, Room 454, DUMC 3664 Durham, NC 27710 / US | Inventor(s) | 01 /
KUAN, Chien-Tsun 202 Hardenbrook Court Cary, North Carolina 27519 / US | 02 /
BIGNER, Darell, D. 5133 Corbett Ridge Road Mebane, North Carolina 27302 / US | 03 /
PASTAN, Ira, H. 11710 Beall Mountain Road Potomac, Maryland 20854 / US | [2008/33] | Representative(s) | Tombling, Adrian George, et al Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [N/P] |
| Former [2008/33] | Tombling, Adrian George, et al Withers & Rogers LLP Goldings House 2 Hays Lane London SE1 2HW / GB | Application number, filing date | 06827329.1 | 31.10.2006 | [2008/33] | WO2006US42735 | Priority number, date | US20050732227P | 31.10.2005 Original published format: US 732227 P | [2008/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007053718 | Date: | 10.05.2007 | Language: | EN | [2007/19] | Type: | A1 Application with search report | No.: | EP1954720 | Date: | 13.08.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.05.2007 takes the place of the publication of the European patent application. | [2008/33] | Search report(s) | International search report - published on: | EP | 10.05.2007 | Classification | IPC: | C07K16/30, A61K39/395, A61P35/00, C12N15/13, A61K47/48, G01N33/68, A61K51/10 | [2008/33] | CPC: |
C07K16/30 (EP,US);
C07K16/28 (US);
A61K47/6817 (EP,US);
A61P29/00 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07K16/1214 (US);
C12N15/00 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/33] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | ANTIKÖRPER UND IMMUNOTOXINE, DIE AUF DAS HUMANE GLYCOPROTEIN NMB ZIELEN | [2008/33] | English: | ANTIBODIES AND IMMUNOTOXINS THAT TARGET HUMAN GLYCOPROTEIN NMB | [2008/33] | French: | ANTICORPS ET IMMUNOTOXINES CIBLANT LA GLYCOPROTEINE HUMAINE NMB | [2008/33] | Entry into regional phase | 15.05.2008 | National basic fee paid | 15.05.2008 | Designation fee(s) paid | 15.05.2008 | Examination fee paid | Examination procedure | 16.05.2008 | Amendment by applicant (claims and/or description) | 16.05.2008 | Examination requested [2008/33] | 06.03.2009 | Application withdrawn by applicant [2009/17] | Fees paid | Renewal fee | 15.05.2008 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX]WO2006071441 (CURAGEN CORP [US], et al) [PX] 1-41 * the whole document *; | [DX] - KUAN C-T ET AL, "MONOCLONAL ANTIBODIES RECOGNIZING HUMAN GPNMBWT/GPNMBSV REACT WITH HUMAN HIGH-GRADE GLIOMAS (HGL)", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, (200307), vol. 44, ISSN 0197-016X, pages 1116 - 1117, XP008070220 [DX] 1-41 * abstract * | [X] - KUAN ET AL, "GPNMB: A new target for human high-grade gliomas (HGL) immunotherapy", NEURO-ONCOLOGY, vol. 7, no. 3, (200507), pages 369 - 369, URL: http://neuro-oncology.dukejournals.org/cgi/reprint/7/3/279, (20070216), XP002420602 [X] 1-41 * abstract * | [X] - KAM FAI TSE ET AL, "CR011, a potent fully human monoclonal antibody-auristatin E conjugated prodrug targeting melanoma", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, (20050416), ISSN 0197-016X, XP002403962 [X] 1-41 * abstract * | [PX] - TSE KAM FAI ET AL, "CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20060215), vol. 12, no. 4, ISSN 1078-0432, pages 1373 - 1382, XP002403963 [PX] 1-41 * abstract * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-05-2018 | [PX] - KUAN CHIEN-TSUN ET AL, "Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 APR 2006, (20060401), vol. 12, no. 7 Pt 1, ISSN 1078-0432, pages 1970 - 1982, XP002420603 [PX] 36-41 * page 1979 * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-05-2797 |